Alar Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	8,216	20,307	9,452	11,942	6,555	2,608
Market Cap Growth	-3.91%	114.84%	-20.85%	82.17%	151.37%	-6.63%
Enterprise Value	5,916	17,972	7,028	11,326	6,046	2,053
Last Close Price	123.00	304.00	141.26	208.00	114.18	45.42
PE Ratio	-	-	520.21	31.21	-	-
PS Ratio	2736.06	7376.39	1624.93	25.45	8193.75	-
PB Ratio	3.47	8.45	3.79	13.31	12.74	4.88
P/TBV Ratio	3.47	8.45	3.79	13.31	12.74	4.88
P/FCF Ratio	-	-	-	30.06	-	-
P/OCF Ratio	-	-	-	29.59	-	-
EV/Sales Ratio	-	6528.21	1208.22	24.14	7557.22	-
EV/EBITDA Ratio	-	-	-	29.22	-	-
EV/EBIT Ratio	-	-	-	29.38	-	-
EV/FCF Ratio	-37.89	-	-	28.51	-	-
Debt / Equity Ratio	0.00	0.00	0	0.00	0.01	0.00
Debt / EBITDA Ratio	-	-	-	0.00	-	-
Debt / FCF Ratio	-	-	-	0.00	-	-
Net Debt / Equity Ratio	-0.97	-0.95	-0.97	-1.00	-0.94	-0.97
Net Debt / EBITDA Ratio	12.38	13.87	37.14	-2.31	10.95	5.71
Net Debt / FCF Ratio	14.74	13.19	22.62	-2.25	14.19	7.97
Asset Turnover	0.00	0.00	0.00	0.63	0.00	-
Quick Ratio	24.61	30.84	44.14	11.98	90.70	116.51
Current Ratio	25.01	31.59	44.33	12.08	92.66	118.67
Return on Equity (ROE)	-4.64%	-3.26%	1.07%	54.21%	-3.79%	-11.34%
Return on Assets (ROA)	-4.69%	-4.16%	-2.41%	32.22%	-5.47%	-10.20%
Return on Invested Capital (ROIC)	-212.65%	-195.31%	-104.19%	2250.88%	-197.02%	-336.68%
Return on Capital Employed (ROCE)	-7.90%	-7.00%	-2.70%	42.90%	-9.00%	-17.40%
Earnings Yield	-1.37%	-0.39%	0.19%	3.20%	-0.30%	-2.46%
FCF Yield	-1.90%	-0.86%	-1.14%	3.33%	-0.52%	-2.49%
Dividend Yield	0.08%	0.03%	0.18%	0.72%	-	-
Payout Ratio	-	-	551.46%	-	-	-
Buyback Yield / Dilution	0.02%	-0.87%	-16.08%	-0.09%	-	-14.21%
Total Shareholder Return	0.10%	-0.84%	-15.90%	0.63%	-	-14.21%